Royal Bank of Canada vs UnitedHealth Group Inc — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while UnitedHealth Group Inc trades at $436.33 (market cap $382.83B). The key difference: UnitedHealth Group Inc is the larger of the two by market cap, and Royal Bank of Canada pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| RY | UNH | |
|---|---|---|
Market Cap | $289.51B | $382.83B |
Sector | Financials | Health |
52-Week High | $217.87 | $431.68 |
52-Week Low | $128.46 | $237.77 |
Dividend Yield | 2.42% | 2.2% |
Enterprise Value | — | $429.52B |
Signals from Pluang's Aura AI — not financial advice
Royal Bank of Canada (RY) trades at $210.88, down 2.11% on the day, amid a bullish technical setup with support near $208 and resistance at $214. The company reported strong Q1 2026 earnings of $2.84 per share, beating estimates, and has a history of recent beats. Revenue grew to $66.53B in 2025, with a net income margin of 31.85% and a solid ROE of 17.17%. Analyst sentiment is mixed but leans positive, with a 43% buy rating.
RY's outlook is supported by consistent earnings performance and a robust dividend, recently increased to $1.76 per share. However, risks include elevated valuation multiples like a P/E of 19.42 and macroeconomic sensitivity. The stock offers stability through its banking diversification but faces headwinds from interest rate volatility and credit quality concerns.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →